Daniela Urueta, MD

Hematology-Oncology Fellow at UT health San Antonio.

[UT Health SA Hematology/Oncology Fellowship @LSOM_HemOnc]

We are excited to announce our Hem/Onc Chief Fellows for the upcoming academic year 26-27! Congratulations on this well-deserved recognition and leadership role! #HemOnc #fellowship #leadership

@DrSAHaddad
@DanielaUruetamd
@mayscancer
@HemOncFellows

[Daniela Urueta, MD @DanielaUruetamd]

And that’s a wrap on #SABCS25
An inspiring week of new research, learning, and presenting (1 oral, 2 posters).
Most of all, grateful for the incredible women advocating for breast cancer patients — a reminder of why I chose oncology.
@LSOM_HemOnc @UTHSAResearch @SABCSSanAntonio

[Marcela Mazo MD @mazo_md]

Congrats to @DanielaUruetamd on her poster presentation today @SABCSSanAntonio #bcsm

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

And here are the final 2 groups! What a remarkable day. The future is bright! @OncLive #SABCS25

[Yuliya Zektser, MD @omgitsyuliaz]

Some moments at the @OncLive National Fellows Forum before @SABCSSanAntonio. It was an exceptional way to network with fellows and faculty, gain invaluable insights to post graduate careers, and get a chance to give a research presentation and receive feedback! Loved it #SABCS25

[Marcela Mazo MD @mazo_md]

Congratulations to our fellows in their poster spotlight! @coltonjones @DanielaUruetamd and equal congratulations to @SabaShaikhMD for an amazing discussion @SABCSSanAntonio @UTHealthSA

[Daniela Urueta, MD @DanielaUruetamd]

✨ Grateful to have a Poster Spotlight Presentation at #SABCS2025, where I discussed our work on GLP-1 receptor agonists and their impact on pCR rates in TNBC.
Thankful for the opportunity.

[Maya Abdallah @MayaAbdallah_MD]

Happening NOW!

Come learn about Duffy-null associated neutrophil count from experts @LaurenMerzMD @Jmarksloan

[Daniela Urueta, MD @DanielaUruetamd]

Another exciting day at #ASH2023 as I present my second poster! Delighted to share my latest findings and contribute to the vital conversation on inclusion in cancer healthcare. It's a privilege to be part of this transformative community! @LatinasInMed @HemOncWomenDocs

[Enrique Diaz @AEDiazMD]

Leaving our Hispanic footprint to #ASH2023 lymphoma research with nothing less than couple of Awards given to my mentees @DanielaUruetamd and @SergioVallejoMD @uthsaim @UTHealthSAMDA
Felicitaciones!!

[Enrique Diaz @AEDiazMD]

More questions to answer with strong data presented by @DanielaUruetamd showing improved survival in Hispanics with B-Lymphoblastic Lymphoma #ASH2023 @UTHealthSAMDA @NHMAmd @LLSusa

[Daniela Urueta, MD @DanielaUruetamd]

Excited to be at #ASH2023, presenting my first poster as a future #HemeOnc fellow! It's an honor to be part of this community, advancing the cause of inclusion in cancer healthcare. Here's to many more milestones in this journey!

[Dr Amol Akhade @SuyogCancer]

Algorithm for metastatic Her2 disease . 2023. Upto 5 lines. I like such money 💰 slides by @stolaney1 @SABCSSanAntonio #SABCS23 @OncoAlert

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

Presenting Racial Differences in 60-Day Readmissions, @MercyCAnyanwu showcases powerful data on healthcare disparities. #SABCS23 @OncLive National Fellows Forum

[Uriel Suárez @UsuarezMD]

AML: flow cytometry approach. Initial key points. ☝🏻

[American Cancer Society @AmericanCancer]

Our updated guideline widens lung cancer screening criteria, helping to detect lung cancer earlier and improve treatment options.
Visit https://t.co/uN5a4PIEik to learn more about these updates.

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

#MonarchE update: Addition of 2 yr abemaciclib to ET results in 7.6% improvement in invasive disease free survival HR 0.680. Distant Recurrence Free Survival also improved 6.7% (HR 0.675). Overall survival immature, but numerically favors abema.

@OncoAlert #ESMO23

[Daniela Urueta, MD @DanielaUruetamd]

🎉 Exciting News! 🏆 Honored to have received the 2023 ASH Abstract Achievement Award for my research on healthcare disparities. Looking forward to presenting at the ASH Annual Meeting in San Diego this December! Thanks to @AEDiazMD who supported me on this journey. #ASH2023 @LatinasInMed @uthsaim

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

Thrilled to see an email from @SABCSSanAntonio announcing the addition of childcare for those who need it! 👏🏻 #SABCS23

Learn more: https://t.co/kLkHZ4PxBE

[Daniela Urueta, MD @DanielaUruetamd]

Thrilled to share that not just one, but TWO of my abstracts have been accepted for poster presentation at #ASH2023! 🎉 San Diego, here I come! 😊 #Hemeonc #latinasinoncology #latinasinmedicine